A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6<sup>+</sup>T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation-Reference-Cited by-同舟云学术

A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6⁺T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation

Published:2023-05-04 Issue:1 Volume:386 Page:80-92
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Li Wei,Crouse Kimberly K,Alley Jennifer,Frisbie Richard K,Fish Susan C,Andreyeva Tatyana A,Reed Lori A,Thorn Mitchell,DiMaggio Giovanni,Donovan Carol B,Bennett Donald,Garren Jeonifer,Oziolor Elias,Qian Jesse,Newman Leah,Vargas Amanda P,Kumpf Steven W,Steyn Stefan J,Schnute Mark E,Thorarensen Atli,Hegen Martin,Stevens Erin,Collinge Mark,Lanz Thomas A,Vincent Fabien,Vincent Michael S,Berstein Gabriel^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference80 articles.

1. Aciro CB Bagal SK Harvey JW Jones LH Mowbray CE Owen RM Sabnis YA Storer RI Yeap SK (2010) inventors, Pfizer, Inc., assignee. Cyclobutenedione derivatives, in PCT Pat Appl WO 2010131145, Issue Date Nov 18, 2010.

2. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells

3. Detectability and reproducibility of plasma levels of chemokines and soluble receptors;Agalliu;Results Immunol,2013

4. IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment?;Atzeni;Expert Opin Biol Ther,2022

5. Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Process Development of PF-07054894, a Squaramide-Based Antagonist of C–C Chemokine Receptor Type 6 (CCR6);Organic Process Research & Development;2024-01-30